Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June ...

While DGX stock has been hammered in the market recently, the smart money may be sensing a bounce-back opportunity.

Quest Diagnostics (DGX) is a strong buy with growth potential, solid margins, and dividend increases. Discover the full ...

Quest Diagnostics Inc. closed 8.75% short of its 52-week high of $182.38, which the company achieved on June 16th.

Prima Mente today announced the launch of Pleiades, a family of large-scale foundation models created to understand the epigenomic and molecular landscape of human disease. Pleiades represents ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

This was the stock's second consecutive day of losses.

Nvidia recently announced that its forthcoming N1 and N1X processors—geared toward laptops and desktops, respectively—will no longer arrive in early 2026 as planned.

Ericsson has reported unremarkable second-quarter results Margins are improving mainly because of cost-cutting measuresThe ...

Switch this week announced a new ultra-dense data center design focused on AI hardware. Known as EVO AI Factories, the new ...

The global cannabis market was worth $26.86 billion in 2022, Spherical Insights & Consulting data shows. Three years later, ...

Uber has partnered with Chinese technology company Baidu to launch self-driving robotaxis in several international markets.